Sponsor
Bioray Laboratories
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Bioray Laboratories appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownUniversal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune DiseasesNCT05859997 · lead sponsor · 2023-05-17
ENROLLING_BY_INVITATIONLIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate CancerNCT04053062 · lead sponsor · 2020-07-16
SUSPENDEDClinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPCNCT06895811 · collaborator · 2025-03-27
ACTIVE_NOT_RECRUITINGUniversal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.NCT06485232 · collaborator · 2025-02-28
NOT_YET_RECRUITINGClinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPCNCT06228404 · collaborator · 2024-03-03
ACTIVE_NOT_RECRUITINGPD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate CancerNCT04768608 · collaborator · 2021-12-23
COMPLETEDSponsor roles
collaborator4
lead sponsor2
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.